PNAS:揭秘民间草药治疗高血压的分子机制

2019-10-11 佚名 生物探索

据悉,目前全球约三分之一的成年人受到高血压的负面威胁,面对这些现状,科学家们渴望找到新的方法来解决日益严重的高血压问题。

据悉,目前全球约三分之一的成年人受到高血压的负面威胁。尽管通过控制饮食或改变生活方式就能有效降低血压,但在某些情况下仍需要药物治疗。甲之蜜糖,乙之砒霜——降压药或许对某些人有效,但却对另一些人无效,此外药物的副作用也不容忽视。

面对这些现状,科学家们渴望找到新的方法来解决日益严重的高血压问题。




人类使用降压植物的大致时间线 图片来源:参考资料

一些科学家将目光投射到历史长河中,他们发现,据考古证据显示早在80万年前,或有直立人或类似物种对这些草药进行了非食物性食用。此外最早的DNA证据也显示,4.8万年前的尼安德特人已有了食用药用植物的现象存在。至于高血压的降压药在坊间历史记录上也有记载:薰衣草,茴香以及洋甘菊等民间常见的植物性药物对其治疗确有奇效。

为什么草药会有降压作用呢?其具体的作用机制是什么呢?加州大学尔湾分校的研究人员开始关注这些问题,尝试给出科学的解答。9月30日,他们在国际重磅刊物《Proceedings of the National Academy of Sciences》(PNAS)上更新了最新研究结果,表示治疗高血压的植物性药物分子机制已被发现。


KCNQ5钾通道激活是降压草药的共有分子机制

Geoff Abbott教授 图片来源:UCI

在该试验中,研究人员首先选取了随机选取了多种草药植物作为实验对象,其中包括薰衣草、茴香、罗勒、百里香、马约兰以及洋甘菊等。接着,在Geoff Abbott教授的领导下,研究人员在对这些植物进行了精华提取,并对这些提取物的共有生物活性特征进行确定。

研究结果显示:当血管平滑肌收缩时,血压升高;当他们放松时,血压下降。让人惊喜地是,这些草药可以激活一种存在于血管平滑肌中的KCNQ5 的特定钾通道, 从而导致血管平滑肌放松,具有了降压的部分合理机制。此外,研究人员还测试了其他尚未被证明具有降压特性的植物,例如香菜和小麦草,发现它们并不能激活KCNQ5钾通道。

值得一提地是,尽管多种草药都能激活KCNQ5的活性,但每种草药所激活的水平却各有不同。其中,薰衣草、茴香籽提取物和洋甘菊在试验中显示是KCNQ5钾通道最有效的活化剂。



Aloperine是激活KCNQ5钾通道的“开关”

接下来,研究人员开始了更深入地研究:究竟是哪种植物化合物在激活钾通道中担任重要角色。

这次,研究人员选择从苦参根着手,其原因在于在中药文献资料中有明文记载苦参根具有降压和血管松弛的特性。于是,试验发现,苦参根中存在一种被称为Aloperine的化学物质(生物碱),它便是是激活KCNQ5钾通道的重要“开关”。

结语

目前市场上的降压药物并不靶向KCNQ5通道。Abbott教授表示:对这些植物性KCNQ5选择性钾通道开放剂的发现,可有助于未来开发针对高血压和KCNQ5功能丧失脑病等疾病的靶向治疗。但我们仍要清醒地认识到,在受体识别、药品研发以及市场投放等运行道路上依旧充满挑战。

原始出处:

Rían W. Manville, Jennifer van der Horst, Kaitlyn E. Redford, et al. KCNQ5 activation is a unifying molecular mechanism shared by genetically and culturally diverse botanical hypotensive folk medicines. PNAS first published September 30, 2019 https://doi.org/10.1073/pnas.1907511116.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (206)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1754679, encodeId=4b321e546793c, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Tue May 19 02:17:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1856347, encodeId=880d185634eec, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Wed Feb 19 22:17:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383073, encodeId=01723830e3dd, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 23 15:39:56 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383027, encodeId=5dab38302ec7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 21 19:33:07 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382971, encodeId=70ee3829e1b7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Tue May 19 17:57:38 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382948, encodeId=95b638294816, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Mon May 18 18:48:57 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382919, encodeId=a37f382919cf, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sun May 17 22:45:24 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382886, encodeId=fc62382886c9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 16 20:18:23 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382847, encodeId=4dfb38284eb1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Fri May 15 14:15:38 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382817, encodeId=6f8e38281ede, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 14 19:07:20 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2020-05-19 zll0637
  2. [GetPortalCommentsPageByObjectIdResponse(id=1754679, encodeId=4b321e546793c, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Tue May 19 02:17:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1856347, encodeId=880d185634eec, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Wed Feb 19 22:17:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383073, encodeId=01723830e3dd, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 23 15:39:56 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383027, encodeId=5dab38302ec7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 21 19:33:07 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382971, encodeId=70ee3829e1b7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Tue May 19 17:57:38 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382948, encodeId=95b638294816, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Mon May 18 18:48:57 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382919, encodeId=a37f382919cf, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sun May 17 22:45:24 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382886, encodeId=fc62382886c9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 16 20:18:23 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382847, encodeId=4dfb38284eb1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Fri May 15 14:15:38 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382817, encodeId=6f8e38281ede, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 14 19:07:20 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2020-02-19 drwjr
  3. [GetPortalCommentsPageByObjectIdResponse(id=1754679, encodeId=4b321e546793c, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Tue May 19 02:17:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1856347, encodeId=880d185634eec, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Wed Feb 19 22:17:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383073, encodeId=01723830e3dd, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 23 15:39:56 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383027, encodeId=5dab38302ec7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 21 19:33:07 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382971, encodeId=70ee3829e1b7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Tue May 19 17:57:38 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382948, encodeId=95b638294816, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Mon May 18 18:48:57 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382919, encodeId=a37f382919cf, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sun May 17 22:45:24 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382886, encodeId=fc62382886c9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 16 20:18:23 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382847, encodeId=4dfb38284eb1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Fri May 15 14:15:38 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382817, encodeId=6f8e38281ede, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 14 19:07:20 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2020-05-23 liqiangfyy

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1754679, encodeId=4b321e546793c, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Tue May 19 02:17:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1856347, encodeId=880d185634eec, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Wed Feb 19 22:17:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383073, encodeId=01723830e3dd, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 23 15:39:56 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383027, encodeId=5dab38302ec7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 21 19:33:07 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382971, encodeId=70ee3829e1b7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Tue May 19 17:57:38 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382948, encodeId=95b638294816, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Mon May 18 18:48:57 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382919, encodeId=a37f382919cf, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sun May 17 22:45:24 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382886, encodeId=fc62382886c9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 16 20:18:23 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382847, encodeId=4dfb38284eb1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Fri May 15 14:15:38 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382817, encodeId=6f8e38281ede, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 14 19:07:20 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2020-05-21 liqiangfyy

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1754679, encodeId=4b321e546793c, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Tue May 19 02:17:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1856347, encodeId=880d185634eec, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Wed Feb 19 22:17:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383073, encodeId=01723830e3dd, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 23 15:39:56 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383027, encodeId=5dab38302ec7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 21 19:33:07 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382971, encodeId=70ee3829e1b7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Tue May 19 17:57:38 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382948, encodeId=95b638294816, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Mon May 18 18:48:57 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382919, encodeId=a37f382919cf, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sun May 17 22:45:24 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382886, encodeId=fc62382886c9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 16 20:18:23 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382847, encodeId=4dfb38284eb1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Fri May 15 14:15:38 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382817, encodeId=6f8e38281ede, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 14 19:07:20 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2020-05-19 liqiangfyy

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1754679, encodeId=4b321e546793c, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Tue May 19 02:17:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1856347, encodeId=880d185634eec, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Wed Feb 19 22:17:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383073, encodeId=01723830e3dd, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 23 15:39:56 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383027, encodeId=5dab38302ec7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 21 19:33:07 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382971, encodeId=70ee3829e1b7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Tue May 19 17:57:38 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382948, encodeId=95b638294816, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Mon May 18 18:48:57 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382919, encodeId=a37f382919cf, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sun May 17 22:45:24 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382886, encodeId=fc62382886c9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 16 20:18:23 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382847, encodeId=4dfb38284eb1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Fri May 15 14:15:38 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382817, encodeId=6f8e38281ede, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 14 19:07:20 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2020-05-18 liqiangfyy

    学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1754679, encodeId=4b321e546793c, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Tue May 19 02:17:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1856347, encodeId=880d185634eec, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Wed Feb 19 22:17:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383073, encodeId=01723830e3dd, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 23 15:39:56 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383027, encodeId=5dab38302ec7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 21 19:33:07 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382971, encodeId=70ee3829e1b7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Tue May 19 17:57:38 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382948, encodeId=95b638294816, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Mon May 18 18:48:57 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382919, encodeId=a37f382919cf, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sun May 17 22:45:24 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382886, encodeId=fc62382886c9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 16 20:18:23 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382847, encodeId=4dfb38284eb1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Fri May 15 14:15:38 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382817, encodeId=6f8e38281ede, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 14 19:07:20 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2020-05-17 liqiangfyy

    学习

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1754679, encodeId=4b321e546793c, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Tue May 19 02:17:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1856347, encodeId=880d185634eec, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Wed Feb 19 22:17:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383073, encodeId=01723830e3dd, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 23 15:39:56 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383027, encodeId=5dab38302ec7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 21 19:33:07 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382971, encodeId=70ee3829e1b7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Tue May 19 17:57:38 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382948, encodeId=95b638294816, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Mon May 18 18:48:57 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382919, encodeId=a37f382919cf, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sun May 17 22:45:24 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382886, encodeId=fc62382886c9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 16 20:18:23 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382847, encodeId=4dfb38284eb1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Fri May 15 14:15:38 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382817, encodeId=6f8e38281ede, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 14 19:07:20 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2020-05-16 liqiangfyy

    学习

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1754679, encodeId=4b321e546793c, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Tue May 19 02:17:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1856347, encodeId=880d185634eec, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Wed Feb 19 22:17:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383073, encodeId=01723830e3dd, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 23 15:39:56 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383027, encodeId=5dab38302ec7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 21 19:33:07 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382971, encodeId=70ee3829e1b7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Tue May 19 17:57:38 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382948, encodeId=95b638294816, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Mon May 18 18:48:57 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382919, encodeId=a37f382919cf, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sun May 17 22:45:24 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382886, encodeId=fc62382886c9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 16 20:18:23 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382847, encodeId=4dfb38284eb1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Fri May 15 14:15:38 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382817, encodeId=6f8e38281ede, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 14 19:07:20 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2020-05-15 liqiangfyy

    学习

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1754679, encodeId=4b321e546793c, content=<a href='/topic/show?id=b5338e217cd' target=_blank style='color:#2F92EE;'>#草药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87217, encryptionId=b5338e217cd, topicName=草药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5b36776883, createdName=zll0637, createdTime=Tue May 19 02:17:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1856347, encodeId=880d185634eec, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Wed Feb 19 22:17:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383073, encodeId=01723830e3dd, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 23 15:39:56 CST 2020, time=2020-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=383027, encodeId=5dab38302ec7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 21 19:33:07 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382971, encodeId=70ee3829e1b7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Tue May 19 17:57:38 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382948, encodeId=95b638294816, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Mon May 18 18:48:57 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382919, encodeId=a37f382919cf, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sun May 17 22:45:24 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382886, encodeId=fc62382886c9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Sat May 16 20:18:23 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382847, encodeId=4dfb38284eb1, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Fri May 15 14:15:38 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=382817, encodeId=6f8e38281ede, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0fc1607984, createdName=liqiangfyy, createdTime=Thu May 14 19:07:20 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2020-05-14 liqiangfyy

    学习

    0

相关资讯

JAMA Pediatr:全球儿童高血压发病率研究

研究首次对儿童高血压的患病率进行了系统研究,为高血压的预防和治疗提供了根据

国家医保局:3亿高血压、糖尿病患者门诊用药可报销一半以上

10月9日,国务院新闻办召开政策例行吹风会,介绍我国完善城乡居民高血压、糖尿病门诊用药保障机制有关情况。澎湃新闻(www.thepaper.cn)从发布会上获悉,国务院常务会议决定完善城乡居民医保高血压、糖尿病门诊用药报销政策,将为3亿参加城乡居民医保并采取药物治疗的“两病”(高血压、糖尿病)患者报销门诊用药的50%以上。同时,正在探索完善“两病”门诊用药的长期处方制度,也将给高血压和糖尿病患者带

Blood:依鲁替尼可诱导高血压和其他心血管事件的发生发展

依鲁替尼对B细胞恶性肿瘤有显著疗效。依鲁替尼与潜在的限制性心脏毒性有关,包括高血压。但在依鲁替尼治疗期间,高血压的长期发病率、严重程度及影响尚不明确。现研究人员对2009-2016年期间的562位采用依鲁替尼治疗的B细胞恶性肿瘤患者的高血压发病情况进行评估。将观察到的高血压发生率与Framingham-心脏预测的高血压发生率相比较。同时,还评估了依鲁替尼诱导性高血压与其他主要心血管事件(MACE,

Hypertension:支链氨基酸浓度是高血压发生较强的危险标志

这项前瞻性研究表明,血浆高浓度的BCAA与新发高血压的风险增加有关。在调整了年龄、性别、体重指数和血脂后,相关性仍然存在。

Diabetes Care:高血压对糖尿病前期与心血管疾病风险之间关联的影响

由此可见,无论高血压状态如何,该人群中糖尿病前期与心血管疾病风险或全因死亡率增加均无关。

Blood:依鲁替尼治疗后的高血压和心血管事件

总的来说,这些数据表明依鲁替尼与高血压的发病率和严重程度的显著增加有关,并且高血压的发生发展可能提示随后发生心脏毒性事件的风险更高。